Nature: With labeling debate over, time to focus on more pressing biotech issues

Screen Shot at AM

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

[In early July], the US Senate passed a bill that will . . . create federal standards for GM labels. . . . Like many good solutions to complex problems, it leaves both sides in the debate feeling hard done by.

. . . .

But . . . quenching the labelling debate could open the door to discussions about more pressing matters. Vast resources — both time and money — have been poured into the labelling debate. There is an opportunity now to redirect those resources.


In June, the [EPA] determined that the agency was not doing enough to cope with the rise of insects resistant to the pesticide produced by some GM crops. . . . And sophisticated gene-editing technologies are helping to bring a new breed of engineered crops to market, yet regulators are still grappling with how to handle them.

Each of these issues is steeped in complex science, and researchers should seize every opportunity to inform — and encourage — discussions around them. . . .[M]any researchers are hesitant to enter the fray surrounding GM crops. But without their input, the discussion is unlikely to progress.

Read full, original post: Researchers and policymakers are now free to tackle the most-pressing GM issues

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend